ResMed Inc. (NYSE:RMD) Shares to Pay Quarterly Dividend of $0.66

ResMed Inc. (NYSE:RMD) announced a quarterly dividend on Thursday, October 29th. Shareholders of record on Thursday, November 12th will be given a dividend of $0.66 per share by the medical equipment provider on Thursday, December 17th. This represents a $2.64 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Thursday, November 12th.

ResMed has raised its dividend by an average of 0.1% annually over the last three years and has raised its dividend annually for the last 13 consecutive years. ResMed has a payout ratio of 25.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect ResMed to earn $13.19 per share next year, which means the company should continue to be able to cover its $2.64 annual dividend with an expected future payout ratio of 20.0%.

ResMed Price Performance

Shares of NYSE RMD opened at $252.00 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.10 and a quick ratio of 2.42. The stock has a market capitalization of $35.44 billion, a price-to-earnings ratio of 24.16, a PEG ratio of 1.53 and a beta of 0.75. The firm’s 50 day simple moving average is $231.83 and its 200-day simple moving average is $225.57. ResMed has a 12 month low of $180.26 and a 12 month high of $277.67.

ResMed (NYSE:RMD) last released its quarterly earnings results on Thursday, October 29th. The medical equipment provider reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.67 by $0.24. The company had revenue of $1.41 billion during the quarter, compared to analysts’ expectations of $1.39 billion. ResMed had a return on equity of 25.58% and a net margin of 26.94%. ResMed’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.55 EPS. Analysts expect that ResMed will post 12.11 EPS for the current year.

Key Stories Impacting ResMed

Here are the key news stories impacting ResMed this week:

• Positive Sentiment: Q1 earnings and revenue beat estimates. ResMed reported fiscal Q1 2027 adjusted earnings of $2.91 per share, above the $2.67 analyst consensus and up from $2.55 a year earlier. Revenue rose 5.9% year over year to $1.41 billion, exceeding the $1.39 billion estimate. The company also reported a 26.94% net margin and 25.58% return on equity, reinforcing the earnings-driven support for RMD. ResMed Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: Dividend maintained at $0.66 per share. ResMed declared a quarterly dividend payable December 17 to shareholders of record November 12. The $2.64 annualized payout represents an approximately 1.0% yield and adds to shareholder returns, although the ex-dividend date may produce normal short-term trading adjustments. ResMed Posts Strong Q1 Results and Shareholder Returns
• Neutral Sentiment: Investors will focus on the outlook and valuation. Earnings-call coverage highlighted the quarterly performance, while ResMed’s shares trade near the upper end of their 52-week range. With a reported price-to-earnings ratio of about 24, continued appreciation may depend on sustaining growth beyond the current 6% revenue expansion. ResMed Q1 2027 Earnings Call Transcript

ResMed Company Profile

ResMed Inc is a medical equipment and software company that develops solutions for sleep-disordered breathing, respiratory conditions and other chronic diseases. The company is best known for its positive airway pressure (PAP) devices used to treat obstructive sleep apnea, along with masks, accessories and related patient support services.

ResMed also provides cloud-connected health technology, including remote-monitoring platforms and software used by healthcare providers, medical equipment suppliers and care organizations.